![]() |
Name |
Chlorophenol B
|
Molecular Formula | C11H12Cl2O3 | |
IUPAC Name* |
3,5-dichloro-2,4-dimethoxy-6-prop-1-enylphenol
|
|
SMILES |
CC=Cc1c(O)c(OC)c(Cl)c(OC)c1Cl
|
|
InChI |
InChI=1S/C11H12Cl2O3/c1-4-5-6-7(12)10(15-2)8(13)11(16-3)9(6)14/h4-5,14H,1-3H3/b5-4+
|
|
InChIKey |
GRULDXRPTOJPMW-SNAWJCMRSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Molecular Weight: | 263.12 | ALogp: | 3.7 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 38.7 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.876 |
Caco-2 Permeability: | -4.671 | MDCK Permeability: | 0.00001910 |
Pgp-inhibitor: | 0.073 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.081 | Plasma Protein Binding (PPB): | 99.80% |
Volume Distribution (VD): | 3.52 | Fu: | 1.93% |
CYP1A2-inhibitor: | 0.933 | CYP1A2-substrate: | 0.975 |
CYP2C19-inhibitor: | 0.68 | CYP2C19-substrate: | 0.874 |
CYP2C9-inhibitor: | 0.693 | CYP2C9-substrate: | 0.939 |
CYP2D6-inhibitor: | 0.15 | CYP2D6-substrate: | 0.879 |
CYP3A4-inhibitor: | 0.492 | CYP3A4-substrate: | 0.537 |
Clearance (CL): | 10.121 | Half-life (T1/2): | 0.468 |
hERG Blockers: | 0.038 | Human Hepatotoxicity (H-HT): | 0.422 |
Drug-inuced Liver Injury (DILI): | 0.283 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.714 | Maximum Recommended Daily Dose: | 0.191 |
Skin Sensitization: | 0.915 | Carcinogencity: | 0.427 |
Eye Corrosion: | 0.013 | Eye Irritation: | 0.932 |
Respiratory Toxicity: | 0.87 |